Dyee Capital, a China-based financial services firm, founded in 2016 by Dezhen Zhu.
Location
Xiamen, Fujian, CN
Founded
2016
Dyee Capital, founded in 2016 by Dezhen Zhu, is a financial services firm based in Xiamen, Fujian Province, China. The firm focuses on investing in later-stage rounds, including Series B, C, and E, with a particular emphasis on the biotechnology and healthcare sectors. Dyee Capital typically engages in substantial investments, as evidenced by their involvement in significant funding rounds.
Notable portfolio companies include BridGene Biosciences, Cloudbreak Therapeutics, MeetYou, and Phanes Therapeutics. The firm's investment philosophy centers on supporting innovative and high-growth potential companies. Dyee Capital offers unique value-add services to its portfolio companies, leveraging its deep industry expertise and extensive network to foster growth and development.
Dyee Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies5
Current Portfolio Count5
Top Investment Stages
Series B3 (60.0%)
Series C1 (20.0%)
Series E1 (20.0%)
Stage Mix
Series B 60%Series C 20%Series E 20%
Concentration shown as share of disclosed investments by stage.